Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours Β· Estimated delivery Sep 5 - Sep 10
Since he and his team began offering the FDA-approved weight loss injections to patients, founder and on-site physician James Mirabile, M.D., FACOG has been pleased with the results
Relative contraindications These are situations where the combination might be possible under very careful supervision but carry elevated risk that must be weighed against potential benefit: Controlled hypertension (even well-managed blood pressure requires closer monitoring on this combination) History of anxiety disorders (phentermine can exacerbate anxiety through CNS stimulation) History of pancreatitis (GLP-1 receptor agonists including tirzepatide carry a theoretical risk of pancreatitis) Gallbladder disease (rapid weight loss from combination therapy increases gallstone risk) Severe gastrointestinal conditions including gastroparesis (tirzepatide further slows already-compromised gastric motility) Kidney disease (dehydration risk from combined GI side effects can worsen renal function) If you fall into any of these categories, the conversation with your provider needs to be particularly thorough
The dual GIP and GLP-1 receptor activation slows gastric emptying, meaning food stays in your stomach longer
We routinely update content to reflect current research and expert advice, provide context (and wit) and ensure our links work
